taking a glp 1 Outpatient Sedation Basics for Patients on GLP-1 Medications What Really Happens When You

Table 1 consolidates recent studies that have identified T2DM as a potential risk factor for PD

What do the STEP and SUMO trials show about bone safety

For others, it is a significant barrier

Seek advice if you experience persistent vomiting or diarrhoea, and maintain adequate hydration during these episodes

Weeks 14: 0.25 mg once a week Weeks 58: 0.5 mg Weeks 912: 1 mg Weeks 1316: 1.7 mg (if needed) Week 17 and beyond: 2.4 mg (maintenance) Weeks 14: 2.5 mg weekly (starting dose) Week 5+: 5 mg weekly Increase by 2.5 mg every 4 weeks if needed Maximum: 15 mg weekly Your provider will help you determine the right pace based on how youre responding